TON November 2015 Vol 8 No 6

Each year the Bonnie J. Addario Lung Cancer Foundation (ALCF) recognizes luminaries in the quest to cure lung cancer with the Addario Lectureship Award. Read More ›

Despite the promise of molecular profiling, approximately 80% of patients with lung cancer lack a defined genotypic mutation, and become resistant when treated with a tyrosine kinase inhibitor. Read More ›

The association of POLE and POLD1 with colorectal cancer risk was demonstrated in 2013. Palles and colleagues studied families with a dominant pattern of inherited colorectal cancer and multiple adenomas through whole genome sequencing. Read More ›

A closer look at the $2.7 trillion spent on healthcare in the United States in 2011 reveals a system of extreme imbalances, characterized by excessive consumption of care on the one hand, and lack of access to necessary care on the other. Read More ›

The International Myeloma Workshop (IMW) is a biannual meeting in which more than 3000 attendees participate. The workshop focuses on increasing the knowledge of physicians and providers who specialize in the biology and treatment of multiple myeloma (MM), as well as dissemination of new findings and emerging advances in the field. Read More ›

It is no secret that developing cancer drugs is a time-consuming and costly endeavor. Although the US Food and Drug Administration (FDA) review represents only a fraction of the entire timeline, accelerated evaluation can still shave years off this process. Read More ›